Levonorgestrel-releasing Intrauterine System Compared to Low Dose Combined Oral Contraceptive Pills for Treatment of Adenomyosis: a Randomized Controlled Trial
Latest Information Update: 24 Nov 2017
Price :
$35 *
At a glance
- Drugs Levonorgestrel (Primary) ; Ethinylestradiol/gestodene
- Indications Dysmenorrhoea; Pelvic pain
- Focus Therapeutic Use
- Acronyms LNGIUSAD
- 20 Nov 2017 Status changed from active, no longer recruiting to completed.
- 22 May 2012 New trial record